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Acyclovir is a commonly used antiviral agent for the treatment
of herpes simplex and herpes zoster infection. According to the
Food and Drug Administration, it is classiﬁed as a category B drug
and is safe for use during pregnancy [1]. Adverse effects of acyclovir
include mild symptoms, such as nausea, vomiting, and diarrhea, to
more severe symptoms, including neutropenia, hepatitis, and Ste-
venseJohnson syndrome [2]. Reversible nephrotoxicity can be
diagnosed in approximately 5e10% of patients undergoing intra-
venous (IV) administration. The precipitation of acyclovir crystals
results in kidney damage and a rapid rise in serum creatinine [3,4].
However, drug-associated complications during pregnancy have
not been documented.
A 33-year-old pregnant woman, G2P1, at 31 weeks' gestation
presented at the outpatient department with a 2-day history of
generalized tiny vesicles on the erythematous base over her trunk
and genital area. She was previously started on oral acyclovir
(800 mg 4 times daily) under the impression of chickenpox by a
dermatologist. Additionally, she reported abdominal tightness,
poor intake, and general weakness. Fetal nonstress test showed
uterine contractions. The patient was admitted for management of
preterm labor in association with chickenpox. Upon admission, her
blood pressure was 118/67 mmHg, dipstick test of urinalysis
showed trace proteins, and laboratory ﬁndings revealed a hemo-
globin level of 10.7 g/dL and a hematocrit of 33.9%. The differential
counts of lymphocytes and monocytes were 10.7% and 11.2%,* Corresponding author. Department of Obstetrics and Gynecology, Taipei
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were within the normal range. The obstetrical ultrasound ﬁndings
were unremarkable, and the results of immunoglobulin G and
immunoglobulin M tests for varicella zoster were negative
The patient was started on ritodrine and nifedipine upon hos-
pitalization for treatment of preterm labor, and vital signs and
intake/output were monitored. She then received IV acyclovir
(750 mg every 8 hours) for progressive skin lesions, with severe
vulvar pain and burning. Unfortunately, decreased urine output
was noted 3 days after commencing IV acyclovir. Follow-up labo-
ratory data showed elevation of serum creatinine (0.72e3.77 mg/
dL). Drug-induced nephropathy was suspected, and acyclovir was
stopped immediately. Urinalysis collected after creatinine elevation
was negative for granular casts and crystals. Renal sonogram was
also normal. The patient was started on aggressive IV ﬂuid hydra-
tion. On Hospital day 6, continuous elevation of creatinine (5.5 mg/
dL) was still noted. Due to the possible inﬂuence of tocolytics on
renal and pulmonary function, a chest X-ray was obtained,
revealing no evidence of pulmonary edema. However, after dis-
cussing and obtaining consent from the patient and her family,
cesarean delivery without corticosteroid injection was performed
at 32 weeks' gestation for breech presentation and deteriorating
renal function. A male baby weighing 1755 g with an Apgar score of
6e8 at 5 minutes was delivered. Patient creatinine levels began to
decline to baseline levels over the following 5 days (Figure 1).
To the best of our knowledge, no previous reports on the issue of
acyclovir-induced nephrotoxicity during pregnancy have been pub-
lished. In this particular case, whether concomitant use of the toco-
lytic agent placed the patient at a higher risk of developing acute
renal injury is unknown. Nevertheless, nephrotoxicity is not a com-
mon side effect of ritodrine andnifedipine. The diagnosis of acyclovir
nephrotoxicity was supported by clinical features and time course of
the acyclovir administration. No other cause was identiﬁed.
Acute renal failure secondary to acyclovir is a well-described
side effect, with the most common mechanism being crystal ne-
phropathy. Other potential mechanisms of injury include acute
interstitial nephritis and acute tubular necrosis [5]. Deterioration in
renal function may develop within 24e48 hours of acyclovir
administration [6]. Risk factors include hypovolemia, rapid IVby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Figure 1. Creatinine levels showing acute renal failure (Day 5) after treatment and after delivery.
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administration, and concomitant use of other nephrotoxic agents.
Early and immediate detection is necessary to prevent morbidity.
Monitoring renal function in hospitalized patients using acyclovir
for longer than 48 hours is strongly suggested. The possibility for
chronic kidney injury is a strong concern if renal insufﬁciency is not
rapidly corrected [7]. Treatment of acyclovir nephrotoxicity is
supportive, with discontinuation or reduction of the drug in addi-
tion to maintaining a high urinary ﬂow rate (>150 cc/h) with IV
ﬂuids and furosemide [5]. In patients that develop severe renal
failure or those who do not respond to treatment, hemodialysis is
an option for removal of the offending drug and to support renal
function [6]. The risk of acyclovir-induced nephrotoxicity can be
minimized with empiric IV ﬂuids to establish euvolemia before
drug administration in order to avoid rapid infusion of the drug
(infuse slowly over 1e2 hours), with dosage adjustment according
to renal function if necessary [7].
Considering the fact that the patient was pregnant at 32 weeks
with preterm labor and deteriorating renal function, early delivery
was a reasonable alternative to rapidly correct her underlying
problems. In conclusion, acyclovir is not uncommonly used in
pregnancy; therefore, clinicians should be alerted to avoid failure of
early detection of nephrotoxicity.Conﬂicts of interest
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